XML 60 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCK PLANS (Tables)
 12 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
The following is a summary of share-based compensation expense including restricted stock units and performance-based restricted stock units granted pursuant to the Company's Amended 2007 Plan and the Amended 2019 Plan, and employee stock purchases made under the Company's 2011 Amended and Restated Employee Stock Purchase Plan (ESPP), based on estimated fair values within the applicable cost and expense lines identified below (in thousands):
 Fiscal Year Ended March 31,
 202420232022
Cost of product revenue$1,330 $1,129 $1,022 
Cost of service revenue8,899 7,286 6,020 
Research and development19,281 17,055 15,505 
Sales and marketing25,375 22,612 19,684 
General and administrative15,914 13,904 13,843 
$70,799 $61,986 $56,074 
Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
Transactions under the Amended 2007 and the Amended 2019 Plan during the fiscal years ended March 31, 2024, 2023 and 2022 are summarized in the table below.
 Restricted Stock Units
 Number of
Awards		Weighted
Average
Fair Value
Outstanding – March 31, 20214,495,613 $28.14 
Granted2,121,937 29.06 
Vested(1,728,994)29.04 
Canceled(260,622)28.07 
Outstanding – March 31, 20224,627,934 $28.23 
Granted3,096,295 33.73 
Vested(1,777,708)28.34 
Canceled(197,050)30.93 
Outstanding – March 31, 20235,749,471 $31.07 
Granted2,446,494 28.87 
Vested(2,067,558)30.08 
Canceled(207,736)31.17 
Outstanding – March 31, 20245,920,671 $30.50 
Schedule of Aggregate Intrinsic Values of Stock Options and Restricted Stock Units
The aggregate intrinsic value of stock options exercised and the fair value of restricted stock units vested at March 31, 2024, 2023 and 2022 were as follows (in thousands):
 Fiscal Year Ended March 31,
  
202420232022
Total fair value of restricted stock unit awards vested$61,130 $61,128 $49,593